Framatome, IBA to Develop At-211 Production Network in Europe and U.S.
February 15, 2025
February 15, 2025
LA GRANGE PARK, Illinois, Feb. 15 -- The American Nuclear Society issued the following news:
* * *
Framatome, IBA to develop At-211 production network in Europe and U.S.
French Nuclear energy company Framatome and Belgian particle accelerator technology company Ion Beam Applications (IBA) have signed a memorandum of understanding to advance the industrial-scale production of the alpha-emitting medical radioisotope astatine-211 across Europe and the United S . . .
* * *
Framatome, IBA to develop At-211 production network in Europe and U.S.
French Nuclear energy company Framatome and Belgian particle accelerator technology company Ion Beam Applications (IBA) have signed a memorandum of understanding to advance the industrial-scale production of the alpha-emitting medical radioisotope astatine-211 across Europe and the United S . . .
